Related Experiment Videos
Anti-inflammatory activity of an imidazopyridine derivative (miroprofen)
Abstract:
Anti-inflammatory activity of 2-[p-(2-imidazo[1,2-a]pyridyl) phenyl]propionic acid (Y-9213, miroprofen) was studied on various experimental models. Miroprofen was found to be as active as indomethacin against the exudative inflammation such as pleuritis in rats induced by Evans blue-carrageenin and the peritonitis in mice induced by acetic acid, and against the local Shwartzman reaction in rabbits. Miroprofen also inhibited the formation of edema induced by carrageenin or kaolin in rats' paws at lower doses. Against the proliferation of connective tissues, miroprofen showed the inhibitory action at higher doses. The ulcerogenic activity of miroprofen in rats was less potent than that of indomethacin, and as active as that of phenylbutazone. These findings indicate that miroprofen may be more effective in suppressing pain responses and acute inflammation accompanied with increased vascular permeability.
Insights
Miroprofen demonstrates potent anti-inflammatory effects comparable to indomethacin in various models. This non-steroidal anti-inflammatory drug shows promise for managing acute inflammation and pain with reduced ulcerogenic potential.
Area of Science:
- Pharmacology
- Inflammation Research
Background:
- Non-steroidal anti-inflammatory drugs (NSAIDs) are widely used for pain and inflammation.
- Developing NSAIDs with improved efficacy and safety profiles remains a key research area.
Purpose of the Study:
- To evaluate the anti-inflammatory and ulcerogenic activities of miroprofen (Y-9213).
- To compare miroprofen's efficacy against established NSAIDs like indomethacin and phenylbutazone.
Main Methods:
- Assessed anti-inflammatory effects in rat pleuritis and peritonitis models.
- Evaluated inhibition of edema formation induced by carrageenin and kaolin.
- Studied effects on the local Shwartzman reaction in rabbits.
- Determined ulcerogenic activity in rats.
Main Results:
- Miroprofen exhibited anti-inflammatory activity comparable to indomethacin in exudative inflammation models.
- It effectively inhibited carrageenin- and kaolin-induced edema.
- Higher doses of miroprofen inhibited connective tissue proliferation.
- Miroprofen displayed less ulcerogenic activity than indomethacin but was similar to phenylbutazone.
Conclusions:
- Miroprofen possesses significant anti-inflammatory properties, particularly for acute conditions.
- Its efficacy in reducing pain and acute inflammation with increased vascular permeability is notable.
- The reduced ulcerogenic potential suggests a favorable safety profile compared to indomethacin.